Qool Therapeutics

What Qool Therapeutics does

Qool Therapeutics is a privately held therapeutics company headquartered in Menlo Park, California, founded in 2005. According to its firmographic profile, the company is dedicated to developing non-invasive, efficient temperature management therapies intended to preserve cells — a medical device / cell preservation platform targeted at healthcare and life sciences applications. The company operates with a very small team of 1-10 employees and has not pursued a public listing.

The firm has raised approximately $8 million in disclosed outside capital, headlined by a 2017 Series 2 financing from BioPacific Ventures, BrilliMedical International Corporation, TAMCAP, Western Technology Investment, and Zhongji Holdings Groups, with earlier seed support from AngelMD and de Anda Capital. Leadership consists of founder Amir Belson (CTO) and Beverly Huss (President & CEO). No products, patents, clinical milestones, regulatory clearances, or named customers are disclosed in the available data, and the public-facing website (qooltherapeutics.com) currently displays content — Indonesian-language online gambling and e-commerce marketplace material — that is entirely misaligned with a therapeutics business, suggesting the domain has been compromised, repurposed, or sold. As a result, the company's commercial status, pipeline stage, and revenue profile cannot be verified from public information.

Name

Qool Therapeutics

Website

https://qooltherapeutics.com

Company type

Private

Founded year

2005

Operating status

Operating

Headcount range

11–50 employees

Short description

Qool Therapeutics is a Menlo Park-based private therapeutics company developing non-invasive temperature management therapies for cell preservation. Founded in 2005, the firm operates with a small team and has raised approximately $8M in disclosed funding.

Ownership category

akta.pro rank

Product category

Medical Devices - Temperature Management / Cell Preservation Therapeutics

SIC

Electromedical & Electrotherapeutic Apparatus (3845)

akta.pro primary industry

Cold Chain, Cryopreservation & Biologics Storage/Handling Technologies (HLAAAJAN)

akta.pro secondary industry

Cold Chain Storage & Cryopreservation Services (LN2/Ultra-low) (HLAGAGAK)

Keywords

• Cell preservation therapy
• Temperature management
• Non-invasive therapeutics
• Biomedical devices
• Cell therapy systems

Headquarters

HQ city

Menlo Park

HQ country

United States

HQ region

North America

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Personnel, Operations, Marketing or Sales, Others

Revenue model

1. Online Slot Gaming: Platform for online slot gaming with server Thailand. Revenue derived from player deposits and gameplay activity.
2. E-commerce Marketplace: Multi-category e-commerce platform selling electronics, fashion, health products, home goods, automotive, and more. Revenue from product sales.

Pricing tiers

Go-to-market motion1 record

Distribution channels3 records

Marketing channels3 records

Core offering

Qool Therapeutics develops non-invasive, efficient temperature management therapies designed to preserve cells. The company's work centers on applying controlled temperature therapy to maintain cell viability for biomedical and therapeutic use cases.

Product overview

No product information is available for Qool Therapeutics. The source content does not contain any information about the company's actual products or services.

Differentiator

Problem solved

Functional benefit

Products and services

• Non-invasive Temperature Management Therapy

Named customers1 record

Segments2 records

Ideal customer profiles1 record

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature1 record

Partnerships

Seven partnerships are on record, tiered core and minor.

• JNEcoreChannel Partner/ Reseller/ DistributorJNE is one of the major logistics and courier services in Indonesia. Partnered for product delivery and order fulfillment services across Indonesia.
• Ninja ExpresscoreChannel Partner/ Reseller/ DistributorIndonesian logistics partner for express delivery and shipment services.
• GoSendcoreChannel Partner/ Reseller/ DistributorOn-demand delivery service partner for fast shipping options.
• SicepatcoreChannel Partner/ Reseller/ DistributorIndonesian logistics company providing delivery services for e-commerce shipments.
• Grab ParcelminorChannel Partner/ Reseller/ DistributorLast-mile delivery partner leveraging Grab's transportation network.
• J&T ExpresscoreChannel Partner/ Reseller/ DistributorMajor Indonesian express delivery company for package shipments.
• AnterminorChannel Partner/ Reseller/ DistributorIndonesian delivery service partner for order fulfillment.

Scale indicators1 record

Recent moves3 records

Expansion highlights2 records

Broad incumbents

• Corning Life Sciences: Manufactures cell culture, cryogenic storage vials, and biopreservation consumables used across cell therapy and biobanking workflows; overlaps with Qool's target use cases under a much larger portfolio.
• Thermo Fisher Scientific (Life Sciences): Broad life-sciences tools and cryogenic storage portfolio including ultralow-temperature freezers, consumables and biopreservation media; relevant broad incumbent with overlapping cold-chain capabilities for cell preservation.
• Sartorius (BIA Separations / CellGenix): Supplies upstream/downstream bioprocessing and cell therapy manufacturing solutions including cryopreservation media; a sizeable incumbent serving the same developers of advanced therapies that Qool targets.

Direct peers

• Cryoport Systems: Provides temperature-controlled logistics and cryopreservation solutions for life sciences, including advanced therapies; directly comparable cold-chain/cryopreservation platform competing for the same regenerative medicine customers.
• Azenta (Brooks Life Sciences): Sample management, biobanking, and cryogenic storage automation for pharma and research; an established peer in cold-chain sample preservation across biorepositories and clinical research.
• BioLife Solutions: Specialty biopreservation/cryopreservation media and storage products for cell and gene therapies; the closest direct comparable to Qool Therapeutics' cell-preservation value proposition and target customers (cell therapy developers, biobanks, CDMOs).

Emerging players

• BMedical Systems: Medical-grade cold chain equipment for blood, vaccines, and biological samples, including solar-powered and portable cold chain; comparable as a niche temperature-management player for biological storage/handling.
• Helmer Scientific (Trinity Biotech): Specialty manufacturer of temperature-controlled storage, including ultralow freezers and plasma/blood storage; a focused niche player whose temperature-management hardware is comparable to Qool's non-invasive preservation premise.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat2 records

Key risks5 records

Key highlights4 records

Customer concentration

• Xx.com/qool_thera
• YouTubeyoutube.com/@LazadaIndonesia
• Facebookfacebook.com/LazadaIndonesia
• LinkedInlinkedin.com/company/qool-therapeutics-inc.
• Instagraminstagram.com/lazada_id

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds2 records

Investors7 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Qool Therapeutics